Loading stock data…
CDIO
$1.88+0.09 (+5.03%)
Market ClosedLast close May 1
Cardio Diagnostics Holdings, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Cardio Diagnostics Holdings, Inc. in the Healthcare sector is trading at $1.88. The stock is currently near its 52-week low of $0.97, remaining 41.4% below its 200-day moving average. Technical signals show neutral RSI of 50 and bullish MACD crossover, explaining why CDIO maintains its current current market pressure. The Whystock Score of 35/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 50) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.88
Potential Upside
5%
Whystock Fair Value$1.97
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targe...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.65M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.66
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-21.75%
Volume
Today's trading volume
76,691
Recent News
Is DXC (DXC) Centralizing Digital And AI Leadership To Reframe Its Long-Term Competitiveness Story?
Earlier this month, DXC Technology appointed longtime executive Russell Jukes as its first Chief Digital Information Officer, giving him responsibility for leading the company’s end-to-end digital and AI agenda and internal technology environment. The move centralizes DXC’s digital, data, and AI efforts under a single leader, signaling a clearer push to embed AI across its services, operations, and workforce capabilities. Next, we’ll examine how consolidating DXC’s digital and AI leadership...
e.l.f. Beauty’s CDIO says she’s responsible for AI’s foundation, but that these tools aren’t an IT mandate
Ekta Chopra, the chief digital information officer of e.l.f. Beauty, acts as a champion of generative AI and helps make it pervasive across the company with AI tools that can assist employees with research inquiries, IT requests, and data analytics.
Cardio Diagnostics Holdings Second Quarter 2025 Earnings: US$0.97 loss per share (vs US$1.71 loss in 2Q 2024)
NasdaqCM:CDIO 1 Year Share Price vs Fair Value Explore Cardio Diagnostics Holdings's Fair Values from the Community and...
Cardio Diagnostics Holdings, Inc. (CDIO): A Bull Case Theory
We came across a bullish thesis on Cardio Diagnostics Holdings, Inc.(CDIO) on Stock Pursuit’s Substack. In this article, we will summarize the bulls’ thesis on CDIO. Cardio Diagnostics Holdings, Inc. (CDIO)’s share was trading at $4.4 as of 3rd June according to Yahoo Finance. Cardio Diagnostics (CDIO), currently trading below net cash with no long-term debt and […]
Cardio Diagnostics Holdings First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Cardio Diagnostics Holdings ( NASDAQ:CDIO ) First Quarter 2025 Results Key Financial Results Net loss: US$1.64m (loss...